OLMA earnings: a positive outcome, +12.8%

On March 16, 2026, Olema Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +12.8% in the window around the event. It had already run -34.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.